Lv3
284 积分 2023-06-26 加入
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
4小时前
已完结
Modern Advanced Therapies for Inflammatory Bowel Diseases: Practical Considerations and Positioning
3天前
已完结
Etrasimod (Velsipity) for Ulcerative Colitis
3天前
已完结
The discovery and development of the sphingosine 1-phosphate receptor modulator ozanimod in ulcerative colitis
3天前
求助中
Etrasimod for the treatment of ulcerative colitis
3天前
已完结
Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐ TNF agent
3天前
已完结
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
4天前
已完结
Real‐world effectiveness of ustekinumab and vedolizumab in TNF‐exposed pediatric patients with ulcerative colitis
4天前
已完结
The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group
4天前
已完结
Real‐world effectiveness of vedolizumab compared to anti‐TNF agents in biologic‐naïve patients with ulcerative colitis: A two‐year propensity‐score‐adjusted analysis from the prospective, observational VEDOIBD‐study
4天前
已完结
皖公网安备34019202002308
